{
    "title": "Individual feed for https://lead-mark.github.io/snippets/InboxNews/INfinance.xml",
    "link": "https://lead-mark.github.io/snippets/InboxNews/INfinance.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-03-18T14:43:10.989084",
    "items": [
        {
            "title": "Intel’s stock is on a five-day hot streak — but it’s still below last month’s highs",
            "link": "https://www.marketwatch.com/story/intels-stock-is-on-a-five-day-hot-streak-but-its-still-below-last-months-highs-3cd74dcc?mod=mw_rss_topstories",
            "description": "Despite excitement over Intel’s new CEO, shares are still below the company’s year-to-date highs — in February, when investors were expecting an immin...",
            "pubDate": "2025-03-18T18:50:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "Your 401(k) may need some all-weather protection",
            "link": "https://www.marketwatch.com/story/your-401-k-may-need-some-all-weather-protection-7ca9095d?mod=mw_rss_topstories",
            "description": "With retail investors in the grip of stock-market turmoil, a fund that protects against all kinds of financial risks seems like a good idea. Is it?",
            "pubDate": "2025-03-18T18:12:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "‘They hate our generation’: My son and daughter-in-law want us to sell our house — and move to Oregon to start a commune",
            "link": "https://www.marketwatch.com/story/they-hate-our-generation-my-son-and-daughter-in-law-want-us-to-sell-our-house-and-move-to-oregon-to-start-a-commune-849b2330?mod=mw_rss_topstories",
            "description": "“They have spent thousands of dollars taking month-long earthship-building classes.”",
            "pubDate": "2025-03-18T17:57:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "‘I’ll retire when I’m dead’: My 401(k) lost $50,000 in the market turmoil. I’m in my early 40s. What should I do now?",
            "link": "https://www.marketwatch.com/story/ill-retire-when-im-dead-my-401-k-lost-50-000-in-the-market-turmoil-im-in-my-early-40s-what-should-i-do-now-98cb9ce9?mod=mw_rss_topstories",
            "description": "“I have no clue how the funds in my 401(k) are invested.”",
            "pubDate": "2025-03-18T17:50:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Sarepta’s stock slammed after patient dies of liver failure. Here’s what Wall Street is saying.",
            "link": "https://www.marketwatch.com/story/sarepta-therapeutics-stock-falls-after-dmm-patient-dies-of-liver-failure-1ba83398?mod=mw_rss_topstories",
            "description": "More than 800 people have been treated with Elevidys, the only approved treatment for Duchenne muscular dystrophy, the company said.",
            "pubDate": "2025-03-18T17:40:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png"
        }
    ]
}